HEADER IMMUNE SYSTEM/INHIBITOR 06-JUN-18 6DN7 TITLE SPRY DOMAIN-CONTAINING SOCS BOX PROTEIN 2 COMPLEXED WITH WDINNN(BAL) TITLE 2 CYCLIC PEPTIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPRY DOMAIN-CONTAINING SOCS BOX PROTEIN 4; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: SSB-4; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: WDINNN(BAL) CYCLIC PEPTIDE INHIBITOR; COMPND 8 CHAIN: B, D; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SPSB4, SSB4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: K12; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606 KEYWDS PROTEASOMAL DEGRADATION, NITRIC OXIDE, INHIBITOR, IMMUNE SYSTEM, KEYWDS 2 IMMUNE SYSTEM-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.H.P.LAW,T.T.CARADOC-DAVIES,R.S.NORTON REVDAT 2 08-JAN-20 6DN7 1 REMARK REVDAT 1 17-APR-19 6DN7 0 JRNL AUTH M.M.SADEK,N.BARLOW,E.W.W.LEUNG,B.J.WILLIAMS-NOONAN,B.K.YAP, JRNL AUTH 2 F.M.SHARIFF,T.T.CARADOC-DAVIES,S.E.NICHOLSON,D.K.CHALMERS, JRNL AUTH 3 P.E.THOMPSON,R.H.P.LAW,R.S.NORTON JRNL TITL A CYCLIC PEPTIDE INHIBITOR OF THE INOS-SPSB PROTEIN-PROTEIN JRNL TITL 2 INTERACTION AS A POTENTIAL ANTI-INFECTIVE AGENT. JRNL REF ACS CHEM. BIOL. V. 13 2930 2018 JRNL REFN ESSN 1554-8937 JRNL PMID 30226743 JRNL DOI 10.1021/ACSCHEMBIO.8B00561 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.61 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 91680 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 4651 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.81 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 6781 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2244 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6412 REMARK 3 BIN R VALUE (WORKING SET) : 0.2224 REMARK 3 BIN FREE R VALUE : 0.2591 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.44 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 369 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3144 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 2 REMARK 3 SOLVENT ATOMS : 640 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.43220 REMARK 3 B22 (A**2) : -5.88440 REMARK 3 B33 (A**2) : 2.45210 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.12520 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.190 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.068 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.066 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.063 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.062 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.946 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3327 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4540 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1113 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 75 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 505 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3327 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 399 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4503 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.59 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 13.40 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -1.8235 8.4011 32.8364 REMARK 3 T TENSOR REMARK 3 T11: -0.0108 T22: -0.0313 REMARK 3 T33: -0.0448 T12: 0.0026 REMARK 3 T13: -0.0152 T23: -0.0013 REMARK 3 L TENSOR REMARK 3 L11: 0.9593 L22: 0.4173 REMARK 3 L33: 0.9404 L12: -0.0055 REMARK 3 L13: -0.0733 L23: 0.1067 REMARK 3 S TENSOR REMARK 3 S11: -0.0151 S12: 0.0240 S13: 0.0411 REMARK 3 S21: -0.0032 S22: 0.0227 S23: -0.0506 REMARK 3 S31: -0.0082 S32: 0.1337 S33: -0.0076 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { C|* } REMARK 3 ORIGIN FOR THE GROUP (A): 21.9079 7.6820 59.4832 REMARK 3 T TENSOR REMARK 3 T11: -0.0596 T22: 0.1020 REMARK 3 T33: -0.1062 T12: 0.0388 REMARK 3 T13: -0.0065 T23: 0.0061 REMARK 3 L TENSOR REMARK 3 L11: 0.7699 L22: 0.3319 REMARK 3 L33: 2.8251 L12: -0.0746 REMARK 3 L13: 0.2204 L23: -0.5198 REMARK 3 S TENSOR REMARK 3 S11: -0.0515 S12: -0.2498 S13: 0.0335 REMARK 3 S21: 0.0424 S22: 0.1240 S23: 0.0379 REMARK 3 S31: -0.1583 S32: -0.6204 S33: -0.0725 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6DN7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1000234588. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95370 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 91682 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 32.610 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.48 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.47400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M MAGNESIUM CHLORIDE HEXAHYDRATE REMARK 280 20 % W/V PEG 3350, PH 5.9, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.72000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -54.69000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 54.69000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE WDINNN(BAL) CYCLIC PEPTIDE INHIBITOR IS CYCLIC PEPTIDE, A REMARK 400 MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: WDINNN(BAL) CYCLIC PEPTIDE INHIBITOR REMARK 400 CHAIN: B, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 5 REMARK 465 HIS A 6 REMARK 465 HIS A 7 REMARK 465 HIS A 8 REMARK 465 HIS A 9 REMARK 465 HIS A 10 REMARK 465 HIS A 11 REMARK 465 SER A 12 REMARK 465 SER A 13 REMARK 465 GLY A 14 REMARK 465 VAL A 15 REMARK 465 ASP A 16 REMARK 465 LEU A 17 REMARK 465 GLY A 18 REMARK 465 THR A 19 REMARK 465 GLU A 20 REMARK 465 ASN A 21 REMARK 465 LEU A 22 REMARK 465 TYR A 23 REMARK 465 PHE A 24 REMARK 465 GLN A 25 REMARK 465 SER A 26 REMARK 465 MET A 27 REMARK 465 GLY A 28 REMARK 465 ALA A 29 REMARK 465 GLU A 30 REMARK 465 PRO A 31 REMARK 465 GLY A 32 REMARK 465 MET C 1 REMARK 465 HIS C 2 REMARK 465 HIS C 3 REMARK 465 HIS C 4 REMARK 465 HIS C 5 REMARK 465 HIS C 6 REMARK 465 HIS C 7 REMARK 465 SER C 8 REMARK 465 SER C 9 REMARK 465 GLY C 10 REMARK 465 VAL C 11 REMARK 465 ASP C 12 REMARK 465 LEU C 13 REMARK 465 GLY C 14 REMARK 465 THR C 15 REMARK 465 GLU C 16 REMARK 465 ASN C 17 REMARK 465 LEU C 18 REMARK 465 TYR C 19 REMARK 465 PHE C 20 REMARK 465 GLN C 21 REMARK 465 SER C 22 REMARK 465 MET C 23 REMARK 465 GLY C 24 REMARK 465 ALA C 25 REMARK 465 GLU C 26 REMARK 465 PRO C 27 REMARK 465 GLY C 28 REMARK 465 ARG C 29 REMARK 465 PRO C 30 REMARK 465 ALA C 31 REMARK 465 PHE C 160 REMARK 465 LEU C 161 REMARK 465 GLY C 162 REMARK 465 PRO C 163 REMARK 465 ASP C 164 REMARK 465 GLU C 165 REMARK 465 ALA C 166 REMARK 465 PHE C 167 REMARK 465 ALA C 168 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 168 CG OD1 OD2 REMARK 470 GLU A 233 CG CD OE1 OE2 REMARK 470 GLU C 229 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 227 -60.43 -90.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN B 6 BAL B 8 -132.53 REMARK 500 ASN D 6 BAL D 8 -129.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 740 DISTANCE = 6.19 ANGSTROMS REMARK 525 HOH A 741 DISTANCE = 6.19 ANGSTROMS REMARK 525 HOH A 742 DISTANCE = 6.34 ANGSTROMS REMARK 525 HOH A 743 DISTANCE = 6.47 ANGSTROMS REMARK 525 HOH A 744 DISTANCE = 6.79 ANGSTROMS REMARK 525 HOH C 665 DISTANCE = 6.42 ANGSTROMS REMARK 525 HOH C 666 DISTANCE = 6.46 ANGSTROMS REMARK 525 HOH C 667 DISTANCE = 6.46 ANGSTROMS REMARK 525 HOH D 118 DISTANCE = 6.08 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Ligand residues BAL B 8 through REMARK 800 TRP B 1 bound to ASN B 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Ligand residues BAL D 8 through REMARK 800 TRP D 1 bound to ASN D 6 DBREF 6DN7 A 28 233 UNP Q96A44 SPSB4_HUMAN 28 233 DBREF 6DN7 B 1 8 PDB 6DN7 6DN7 1 8 DBREF 6DN7 C 24 229 UNP Q96A44 SPSB4_HUMAN 28 233 DBREF 6DN7 D 1 8 PDB 6DN7 6DN7 1 8 SEQADV 6DN7 MET A 5 UNP Q96A44 INITIATING METHIONINE SEQADV 6DN7 HIS A 6 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 HIS A 7 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 HIS A 8 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 HIS A 9 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 HIS A 10 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 HIS A 11 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 SER A 12 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 SER A 13 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 GLY A 14 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 VAL A 15 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 ASP A 16 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 LEU A 17 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 GLY A 18 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 THR A 19 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 GLU A 20 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 ASN A 21 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 LEU A 22 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 TYR A 23 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 PHE A 24 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 GLN A 25 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 SER A 26 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 MET A 27 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 MET C 1 UNP Q96A44 INITIATING METHIONINE SEQADV 6DN7 HIS C 2 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 HIS C 3 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 HIS C 4 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 HIS C 5 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 HIS C 6 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 HIS C 7 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 SER C 8 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 SER C 9 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 GLY C 10 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 VAL C 11 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 ASP C 12 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 LEU C 13 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 GLY C 14 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 THR C 15 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 GLU C 16 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 ASN C 17 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 LEU C 18 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 TYR C 19 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 PHE C 20 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 GLN C 21 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 SER C 22 UNP Q96A44 EXPRESSION TAG SEQADV 6DN7 MET C 23 UNP Q96A44 EXPRESSION TAG SEQRES 1 A 229 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 229 GLY THR GLU ASN LEU TYR PHE GLN SER MET GLY ALA GLU SEQRES 3 A 229 PRO GLY ARG PRO ALA ARG LEU ASP GLN LEU LEU ASP MET SEQRES 4 A 229 PRO ALA ALA GLY LEU ALA VAL GLN LEU ARG HIS ALA TRP SEQRES 5 A 229 ASN PRO GLU ASP ARG SER LEU ASN VAL PHE VAL LYS ASP SEQRES 6 A 229 ASP ASP ARG LEU THR PHE HIS ARG HIS PRO VAL ALA GLN SEQRES 7 A 229 SER THR ASP GLY ILE ARG GLY LYS VAL GLY HIS ALA ARG SEQRES 8 A 229 GLY LEU HIS ALA TRP GLN ILE ASN TRP PRO ALA ARG GLN SEQRES 9 A 229 ARG GLY THR HIS ALA VAL VAL GLY VAL ALA THR ALA ARG SEQRES 10 A 229 ALA PRO LEU HIS SER VAL GLY TYR THR ALA LEU VAL GLY SEQRES 11 A 229 SER ASP ALA GLU SER TRP GLY TRP ASP LEU GLY ARG SER SEQRES 12 A 229 ARG LEU TYR HIS ASP GLY LYS ASN GLN PRO GLY VAL ALA SEQRES 13 A 229 TYR PRO ALA PHE LEU GLY PRO ASP GLU ALA PHE ALA LEU SEQRES 14 A 229 PRO ASP SER LEU LEU VAL VAL LEU ASP MET ASP GLU GLY SEQRES 15 A 229 THR LEU SER PHE ILE VAL ASP GLY GLN TYR LEU GLY VAL SEQRES 16 A 229 ALA PHE ARG GLY LEU LYS GLY LYS LYS LEU TYR PRO VAL SEQRES 17 A 229 VAL SER ALA VAL TRP GLY HIS CYS GLU VAL THR MET ARG SEQRES 18 A 229 TYR ILE ASN GLY LEU ASP PRO GLU SEQRES 1 B 7 TRP ASP ILE ASN ASN ASN BAL SEQRES 1 C 229 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 C 229 GLY THR GLU ASN LEU TYR PHE GLN SER MET GLY ALA GLU SEQRES 3 C 229 PRO GLY ARG PRO ALA ARG LEU ASP GLN LEU LEU ASP MET SEQRES 4 C 229 PRO ALA ALA GLY LEU ALA VAL GLN LEU ARG HIS ALA TRP SEQRES 5 C 229 ASN PRO GLU ASP ARG SER LEU ASN VAL PHE VAL LYS ASP SEQRES 6 C 229 ASP ASP ARG LEU THR PHE HIS ARG HIS PRO VAL ALA GLN SEQRES 7 C 229 SER THR ASP GLY ILE ARG GLY LYS VAL GLY HIS ALA ARG SEQRES 8 C 229 GLY LEU HIS ALA TRP GLN ILE ASN TRP PRO ALA ARG GLN SEQRES 9 C 229 ARG GLY THR HIS ALA VAL VAL GLY VAL ALA THR ALA ARG SEQRES 10 C 229 ALA PRO LEU HIS SER VAL GLY TYR THR ALA LEU VAL GLY SEQRES 11 C 229 SER ASP ALA GLU SER TRP GLY TRP ASP LEU GLY ARG SER SEQRES 12 C 229 ARG LEU TYR HIS ASP GLY LYS ASN GLN PRO GLY VAL ALA SEQRES 13 C 229 TYR PRO ALA PHE LEU GLY PRO ASP GLU ALA PHE ALA LEU SEQRES 14 C 229 PRO ASP SER LEU LEU VAL VAL LEU ASP MET ASP GLU GLY SEQRES 15 C 229 THR LEU SER PHE ILE VAL ASP GLY GLN TYR LEU GLY VAL SEQRES 16 C 229 ALA PHE ARG GLY LEU LYS GLY LYS LYS LEU TYR PRO VAL SEQRES 17 C 229 VAL SER ALA VAL TRP GLY HIS CYS GLU VAL THR MET ARG SEQRES 18 C 229 TYR ILE ASN GLY LEU ASP PRO GLU SEQRES 1 D 7 TRP ASP ILE ASN ASN ASN BAL HET BAL B 8 5 HET BAL D 8 5 HET CL A 301 1 HET CL C 301 1 HETNAM BAL BETA-ALANINE HETNAM CL CHLORIDE ION FORMUL 2 BAL 2(C3 H7 N O2) FORMUL 5 CL 2(CL 1-) FORMUL 7 HOH *640(H2 O) HELIX 1 AA1 PRO A 34 MET A 43 1 10 HELIX 2 AA2 GLY A 47 HIS A 54 1 8 HELIX 3 AA3 PRO A 105 ARG A 109 5 5 HELIX 4 AA4 LEU C 33 MET C 39 1 7 HELIX 5 AA5 GLY C 43 HIS C 50 1 8 HELIX 6 AA6 PRO C 101 ARG C 105 5 5 SHEET 1 AA1 3 TRP A 56 ARG A 61 0 SHEET 2 AA1 3 SER A 83 GLY A 89 -1 O ARG A 88 N ASN A 57 SHEET 3 AA1 3 HIS A 125 VAL A 127 -1 O SER A 126 N THR A 84 SHEET 1 AA2 7 TRP A 56 ARG A 61 0 SHEET 2 AA2 7 SER A 83 GLY A 89 -1 O ARG A 88 N ASN A 57 SHEET 3 AA2 7 TYR A 210 ALA A 215 -1 O ALA A 215 N ASP A 85 SHEET 4 AA2 7 VAL A 114 ALA A 118 -1 N ALA A 118 O TYR A 210 SHEET 5 AA2 7 SER A 139 ASP A 143 -1 O TRP A 140 N VAL A 117 SHEET 6 AA2 7 ARG A 148 HIS A 151 -1 O TYR A 150 N GLY A 141 SHEET 7 AA2 7 VAL A 159 ALA A 160 -1 O VAL A 159 N LEU A 149 SHEET 1 AA3 7 VAL A 65 VAL A 67 0 SHEET 2 AA3 7 THR A 74 ARG A 77 -1 O HIS A 76 N PHE A 66 SHEET 3 AA3 7 GLU A 221 LEU A 230 -1 O VAL A 222 N PHE A 75 SHEET 4 AA3 7 LEU A 97 ASN A 103 -1 N GLN A 101 O ARG A 225 SHEET 5 AA3 7 SER A 176 ASP A 182 -1 O LEU A 177 N ILE A 102 SHEET 6 AA3 7 THR A 187 VAL A 192 -1 O THR A 187 N ASP A 182 SHEET 7 AA3 7 GLN A 195 PHE A 201 -1 O ALA A 200 N LEU A 188 SHEET 1 AA4 3 TRP C 52 ARG C 57 0 SHEET 2 AA4 3 SER C 79 GLY C 85 -1 O ARG C 84 N ASN C 53 SHEET 3 AA4 3 HIS C 121 VAL C 123 -1 O SER C 122 N THR C 80 SHEET 1 AA5 7 TRP C 52 ARG C 57 0 SHEET 2 AA5 7 SER C 79 GLY C 85 -1 O ARG C 84 N ASN C 53 SHEET 3 AA5 7 TYR C 206 ALA C 211 -1 O ALA C 211 N ASP C 81 SHEET 4 AA5 7 VAL C 110 ALA C 114 -1 N ALA C 114 O TYR C 206 SHEET 5 AA5 7 SER C 135 ASP C 139 -1 O TRP C 136 N VAL C 113 SHEET 6 AA5 7 ARG C 144 HIS C 147 -1 O TYR C 146 N GLY C 137 SHEET 7 AA5 7 VAL C 155 ALA C 156 -1 O VAL C 155 N LEU C 145 SHEET 1 AA6 7 VAL C 61 VAL C 63 0 SHEET 2 AA6 7 THR C 70 ARG C 73 -1 O HIS C 72 N PHE C 62 SHEET 3 AA6 7 GLU C 217 LEU C 226 -1 O VAL C 218 N PHE C 71 SHEET 4 AA6 7 LEU C 93 ASN C 99 -1 N GLN C 97 O ARG C 221 SHEET 5 AA6 7 SER C 172 ASP C 178 -1 O LEU C 173 N ILE C 98 SHEET 6 AA6 7 THR C 183 VAL C 188 -1 O ILE C 187 N LEU C 174 SHEET 7 AA6 7 GLN C 191 PHE C 197 -1 O ALA C 196 N LEU C 184 LINK N TRP B 1 C BAL B 8 1555 1555 1.37 LINK C ASN B 6 N BAL B 8 1555 1555 1.35 LINK N TRP D 1 C BAL D 8 1555 1555 1.41 LINK C ASN D 6 N BAL D 8 1555 1555 1.39 CISPEP 1 TYR A 161 PRO A 162 0 4.48 CISPEP 2 TYR C 157 PRO C 158 0 0.76 SITE 1 AC1 3 THR A 130 ALA A 131 HOH D 112 SITE 1 AC2 2 THR C 126 ALA C 127 SITE 1 AC3 11 LYS A 205 HOH A 430 ASP B 2 ASN B 6 SITE 2 AC3 11 HOH B 102 HOH B 108 ARG C 142 GLY C 149 SITE 3 AC3 11 ASN C 151 GLN C 152 PRO C 153 SITE 1 AC4 14 ARG A 146 GLY A 153 LYS A 154 ASN A 155 SITE 2 AC4 14 GLN A 156 PRO A 157 HOH A 595 LYS C 201 SITE 3 AC4 14 HOH C 406 ASP D 2 ASN D 6 HOH D 101 SITE 4 AC4 14 HOH D 103 HOH D 105 CRYST1 54.690 65.440 69.180 90.00 103.60 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018285 0.000000 0.004424 0.00000 SCALE2 0.000000 0.015281 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014872 0.00000